• Water Ways Technologies (WWT) has announced a private placement for gross proceeds of up to C$313,950
  • The company will issue up to 2,415,000 units at a price of $0.13 per unit
  • The company also announced a private placement of convertible debentures for gross proceeds of up to $102,000
  • Water Ways designed the system for the specific needs of cannabis growers and cultivators worldwide
  • Water Ways Technologies Inc. (WWT) opened trading at C$0.125 per share

Water Ways Technologies (WWT) has announced a private placement for gross proceeds of up to C$313,950.

The company will issue up to 2,415,000 units at a price of $0.13 per unit. Each unit is comprised of one common share and one-half of one common share purchase warrant. Each whole warrant is exercisable into one common share.

The company announced a concurrent private placement of up to 10 convertible debenture units at a price of $10,200 per CD unit for gross proceeds of up to $102,000. Each convertible debenture unit consists of one unsecured convertible debenture with a principal amount of $10,200 and 42,500 half CD share purchase warrants. Each whole CD warrant is exercisable into one additional common share.

Water Ways uses Israeli-based agriculture technology to provide water irrigation solutions to agricultural producers. It competes in the global irrigation water systems market with a focus on developing solutions with commercial applications.

Water Ways Technologies Inc. (WWT) opened trading at C$0.125 per share.


More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.